Last synced from Twitter 83d ago
New Map of the Immune Landscape in Pancreatic Cancer Could Guide Future Personalized Immunotherapy Treatments
The analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.
Immune Checkpoint Inhibitor Therapy May Induce Inflammatory Activity in Large Arteries
This study found that immune checkpoint inhibitor therapy in patients with cancer could aggravate cardiovascular inflammation and subsequent cardiovascular or cerebrovascular events.
FDA Approves FoundationOne CDx for Larotrectinib in NTRK+ Tumors
The FDA has approved the FoundationOne CDx comprehensive genomic test as a companion diagnostic for larotrectinib (Vitrakvi) to identify patients with NTRK1/2/3 gene fusions across all solid tumors.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Nerivio Device Granted Clearance for Acute Treatment of Chronic Migraine
The Theranica Biotherapeutics remote electrical neuromodulation device is now cleared for the acute treatment of migraine with or without aura in adults, without limitation to episodic migraine.
Improving Education on Nonmotor Focal Seizure Identification
The lead investigator of the study and assistant professor of neurology at University of Colorado School of Medicine, Jacob Pellinen, MD, spoke to the importance of identifying nonmotor seizures.
The Exponential Growth of AI in Brain Care and Treatment
Italian researchers analyze more than a decade of applied AI for brain care.
The Need for Genomic Testing Recognized During Breast Cancer Awareness Month
In an interview with Targeted Oncology, Daniel A. Vorobiof, MD, discussed the evolution of the breast cancer treatment landscape and the emerging role of genomic testing in this space during Breast Cancer Awareness Month.
Getting to the Heart of Cardiac Biomarkers
Wednesday, October 28, 2020 at 08:00 PM Eastern Daylight Time.
Study: CLABSI, CAUTI Rates Higher for COVID Patients
CAUTI rates were 83% higher and CLABSI rates were 65% higher in the COVID-19 units compared to the non-COVID-19 units.
FDA Clears AstraZeneca COVID-19 Vaccine to Resume US Trial
The conclusion to the independent safety review punctuates a 50-day period of scrutiny and discussion around 2 non-fatal adverse events reported in patients.
Study Analyzing Daratumumab to Treat Patients with Multiple Myeloma Induces Positive Topline Results
Genmab recently announced positive topline results from part 2 of the Phase 3 CASSIOPEIA study examining daratumumab monotherapy as maintenance therapy to treat patients diagnosed with multiple myeloma.
Breast Cancer Quiz
When it comes to your breast health, don't be fooled by rumors and misinformation. Test your knowledge of 6 common beliefs about breast cancer.